Phase I Trial of THE-0504 in Solid Tumors Initiated
A phase I clinical trial is underway to assess the safety and tolerability of THE-0504 in patients with solid tumors.
Therapeutic Area
Therapeutic area intelligence for Antitumor with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.